Why the study?
Do pharmacologic, electrical, and surgical interventions reduce mortality in patients with Hypertrophic Cardiomyopathy?
Do pharmacologic, electrical, and surgical interventions reduce mortality in patients with Hypertrophic Cardiomyopathy?
Modern management strategies including pharmacologic, electrical, and surgical interventions have successfully reduced HCM mortality to 0.5% per year.
No takes yet. Share an insight, caveat, or question.
Supports low HCM mortality with modern care; leaves open optimal intervention sequencing in prospective studies.
Barry J. Maron (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: